Literature DB >> 15036265

Involvement of stromal proteoglycans in tumour progression.

Yanusz Wegrowski1, Francois-Xavier Maquart.   

Abstract

Glycosaminoglycans (GAGs) and proteoglycans (PGs) belong to a class of extracellular macromolecules necessary for the growth of any multicellular structures, including tumours. Transformed cells induce stromal reaction either per se or by activation of the mesenchymal cells. Tumour stroma contains several chondroitin sulphate and heparan sulphate proteoglycans. These proteoglycans and their glycosaminoglycan chains modify cell behaviour by interacting with different molecules such as growth factors, cytokines, chemokines, proteinases and their inhibitors. This review describes the main proteoglycans of tumour stoma and discusses their implication in the regulation of the activity of extracellular proteins and peptides.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15036265     DOI: 10.1016/j.critrevonc.2003.10.005

Source DB:  PubMed          Journal:  Crit Rev Oncol Hematol        ISSN: 1040-8428            Impact factor:   6.312


  20 in total

1.  Phylogenetic and mutational analyses reveal key residues for UDP-glucuronic acid binding and activity of beta1,3-glucuronosyltransferase I (GlcAT-I).

Authors:  Magali Fondeur-Gelinotte; Virginie Lattard; Rafael Oriol; Rosella Mollicone; Jean-Claude Jacquinet; Guillermo Mulliert; Sandrine Gulberti; Patrick Netter; Jacques Magdalou; Mohamed Ouzzine; Sylvie Fournel-Gigleux
Journal:  Protein Sci       Date:  2006-07       Impact factor: 6.725

2.  Cell surface chondroitin sulfate glycosaminoglycan in melanoma: role in the activation of pro-MMP-2 (pro-gelatinase A).

Authors:  Joji Iida; Krista L Wilhelmson; Janet Ng; Peter Lee; Charlotte Morrison; Eric Tam; Christopher M Overall; James B McCarthy
Journal:  Biochem J       Date:  2007-05-01       Impact factor: 3.857

Review 3.  Collagen XV: exploring its structure and role within the tumor microenvironment.

Authors:  Anthony George Clementz; Ann Harris
Journal:  Mol Cancer Res       Date:  2013-09-16       Impact factor: 5.852

4.  The PG500 series: novel heparan sulfate mimetics as potent angiogenesis and heparanase inhibitors for cancer therapy.

Authors:  K Dredge; E Hammond; K Davis; C P Li; L Liu; K Johnstone; P Handley; N Wimmer; T J Gonda; A Gautam; V Ferro; I Bytheway
Journal:  Invest New Drugs       Date:  2009-04-09       Impact factor: 3.850

5.  Increased expression of chondroitin sulphate proteoglycans in rat hepatocellular carcinoma tissues.

Authors:  Xiao-Li Jia; Si-Yuan Li; Shuang-Suo Dang; Yan-An Cheng; Xin Zhang; Wen-Jun Wang; Clare E Hughes; Bruce Caterson
Journal:  World J Gastroenterol       Date:  2012-08-14       Impact factor: 5.742

6.  Tissue proteomics reveals differential and compartment-specific expression of the homologs transgelin and transgelin-2 in lung adenocarcinoma and its stroma.

Authors:  Jung-Hyun Rho; Michael H A Roehrl; Julia Y Wang
Journal:  J Proteome Res       Date:  2009-12       Impact factor: 4.466

7.  Lumican expression, localization and antitumor activity in prostate cancer.

Authors:  Vivien J Coulson-Thomas; Yvette M Coulson-Thomas; Tarsis F Gesteira; Claudia A Andrade de Paula; Celia R W Carneiro; Valdemar Ortiz; Leny Toma; Winston W-Y Kao; Helena B Nader
Journal:  Exp Cell Res       Date:  2013-02-08       Impact factor: 3.905

8.  Heparan sulfate mimetic PG545-mediated antilymphoma effects require TLR9-dependent NK cell activation.

Authors:  Todd V Brennan; Liwen Lin; Joshua D Brandstadter; Victoria R Rendell; Keith Dredge; Xiaopei Huang; Yiping Yang
Journal:  J Clin Invest       Date:  2015-12-07       Impact factor: 14.808

9.  The effect of substitution of the N-acetyl groups of N-acetylgalactosamine residues in chondroitin sulfate on its degradation by chondroitinase ABC.

Authors:  Subbarao V Madhunapantula; Rajeshwara N Achur; Veer P Bhavanandan; D Channe Gowda
Journal:  Glycoconj J       Date:  2007-05-29       Impact factor: 2.916

10.  Dermatan sulfate domains defined by the novel antibody GD3A12, in normal tissues and ovarian adenocarcinomas.

Authors:  Gerdy B Ten Dam; Shuhei Yamada; Fumi Kobayashi; Anurag Purushothaman; Els M A van de Westerlo; Johan Bulten; Anders Malmström; Kazuyuki Sugahara; Leon F Massuger; Toin H van Kuppevelt
Journal:  Histochem Cell Biol       Date:  2009-04-10       Impact factor: 4.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.